247 related articles for article (PubMed ID: 26375402)
1. Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brain.
Civiero L; Cirnaru MD; Beilina A; Rodella U; Russo I; Belluzzi E; Lobbestael E; Reyniers L; Hondhamuni G; Lewis PA; Van den Haute C; Baekelandt V; Bandopadhyay R; Bubacco L; Piccoli G; Cookson MR; Taymans JM; Greggio E
J Neurochem; 2015 Dec; 135(6):1242-56. PubMed ID: 26375402
[TBL] [Abstract][Full Text] [Related]
2. Prospective Role of PAK6 and 14-3-3γ as Biomarkers for Parkinson's Disease.
Giusto E; Maistrello L; Iannotta L; Giusti V; Iovino L; Bandopadhyay R; Antonini A; Bubacco L; Barresi R; Plotegher N; Greggio E; Civiero L
J Parkinsons Dis; 2024; 14(3):495-506. PubMed ID: 38640169
[TBL] [Abstract][Full Text] [Related]
3. The neurobiology of LRRK2 and its role in the pathogenesis of Parkinson's disease.
Rideout HJ; Stefanis L
Neurochem Res; 2014; 39(3):576-92. PubMed ID: 23729298
[TBL] [Abstract][Full Text] [Related]
4. Human R1441C LRRK2 regulates the synaptic vesicle proteome and phosphoproteome in a Drosophila model of Parkinson's disease.
Islam MS; Nolte H; Jacob W; Ziegler AB; Pütz S; Grosjean Y; Szczepanowska K; Trifunovic A; Braun T; Heumann H; Heumann R; Hovemann B; Moore DJ; Krüger M
Hum Mol Genet; 2016 Dec; 25(24):5365-5382. PubMed ID: 27794539
[TBL] [Abstract][Full Text] [Related]
5. Roc, the G-domain of the Parkinson's disease-associated protein LRRK2.
Park Y; Liao J; Hoang QQ
Trends Biochem Sci; 2022 Dec; 47(12):1038-1047. PubMed ID: 35840518
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity.
West AB; Moore DJ; Biskup S; Bugayenko A; Smith WW; Ross CA; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16842-7. PubMed ID: 16269541
[TBL] [Abstract][Full Text] [Related]
7. PAK6-mediated phosphorylation of PPP2R2C regulates LRRK2-PP2A complex formation.
Iannotta L; Emanuele M; Favetta G; Tombesi G; Vandewynckel L; Lara Ordóñez AJ; Saliou JM; Drouyer M; Sibran W; Civiero L; Nichols RJ; Athanasopoulos PS; Kortholt A; Chartier-Harlin MC; Greggio E; Taymans JM
Front Mol Neurosci; 2023; 16():1269387. PubMed ID: 38169846
[TBL] [Abstract][Full Text] [Related]
8. Membrane remodeling properties of the Parkinson's disease protein LRRK2.
Wang X; Espadas J; Wu Y; Cai S; Ge J; Shao L; Roux A; De Camilli P
Proc Natl Acad Sci U S A; 2023 Oct; 120(43):e2309698120. PubMed ID: 37844218
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2.
Deng X; Dzamko N; Prescott A; Davies P; Liu Q; Yang Q; Lee JD; Patricelli MP; Nomanbhoy TK; Alessi DR; Gray NS
Nat Chem Biol; 2011 Apr; 7(4):203-5. PubMed ID: 21378983
[TBL] [Abstract][Full Text] [Related]
10. The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity.
Stormo AED; Shavarebi F; FitzGibbon M; Earley EM; Ahrendt H; Lum LS; Verschueren E; Swaney DL; Skibinski G; Ravisankar A; van Haren J; Davis EJ; Johnson JR; Von Dollen J; Balen C; Porath J; Crosio C; Mirescu C; Iaccarino C; Dauer WT; Nichols RJ; Wittmann T; Cox TC; Finkbeiner S; Krogan NJ; Oakes SA; Hiniker A
J Cell Biol; 2022 Apr; 221(4):. PubMed ID: 35266954
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in targeting leucine-rich repeat kinase 2 as a potential strategy for the treatment of Parkinson's disease.
Cao R; Chen C; Wen J; Zhao W; Zhang C; Sun L; Yuan L; Wu C; Shan L; Xi M; Sun H
Bioorg Chem; 2023 Dec; 141():106906. PubMed ID: 37837728
[TBL] [Abstract][Full Text] [Related]
12. The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation.
Greggio E; Zambrano I; Kaganovich A; Beilina A; Taymans JM; Daniëls V; Lewis P; Jain S; Ding J; Syed A; Thomas KJ; Baekelandt V; Cookson MR
J Biol Chem; 2008 Jun; 283(24):16906-14. PubMed ID: 18397888
[TBL] [Abstract][Full Text] [Related]
13. The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling.
Dzamko N; Inesta-Vaquera F; Zhang J; Xie C; Cai H; Arthur S; Tan L; Choi H; Gray N; Cohen P; Pedrioli P; Clark K; Alessi DR
PLoS One; 2012; 7(6):e39132. PubMed ID: 22723946
[TBL] [Abstract][Full Text] [Related]
14. Development of a highly potent and selective degrader of LRRK2.
Hatcher JM; Zwirek M; Sarhan AR; Vatsan PS; Tonelli F; Alessi DR; Davies P; Gray NS
Bioorg Med Chem Lett; 2023 Oct; 94():129449. PubMed ID: 37591317
[TBL] [Abstract][Full Text] [Related]
15. Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases.
Steger M; Tonelli F; Ito G; Davies P; Trost M; Vetter M; Wachter S; Lorentzen E; Duddy G; Wilson S; Baptista MA; Fiske BK; Fell MJ; Morrow JA; Reith AD; Alessi DR; Mann M
Elife; 2016 Jan; 5():. PubMed ID: 26824392
[TBL] [Abstract][Full Text] [Related]
16. LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model.
Alegre-Abarrategui J; Christian H; Lufino MM; Mutihac R; Venda LL; Ansorge O; Wade-Martins R
Hum Mol Genet; 2009 Nov; 18(21):4022-34. PubMed ID: 19640926
[TBL] [Abstract][Full Text] [Related]
17. PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domain.
Malik AU; Karapetsas A; Nirujogi RS; Chatterjee D; Phung TK; Wightman M; Gourlay R; Morrice N; Mathea S; Knapp S; Alessi DR
Biochem J; 2022 Sep; 479(18):1941-1965. PubMed ID: 36040231
[TBL] [Abstract][Full Text] [Related]
18. The Parkinson's disease protein LRRK2 impairs proteasome substrate clearance without affecting proteasome catalytic activity.
Lichtenberg M; Mansilla A; Zecchini VR; Fleming A; Rubinsztein DC
Cell Death Dis; 2011 Aug; 2(8):e196. PubMed ID: 21866175
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the function of leucine-rich repeat kinase 2 and targeting its dysfunction in disease.
Lewis PA; Alessi DR
Biochem Soc Trans; 2012 Oct; 40(5):1039-41. PubMed ID: 22988861
[TBL] [Abstract][Full Text] [Related]
20. The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research.
Langston RG; Rudenko IN; Cookson MR
Biochem J; 2016 Feb; 473(3):221-32. PubMed ID: 26811536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
